Atrion Corp
Fermé
459.88
Résumé
Variation du prix de l'action
24h
Min
459.88
Max
459.88
Prochains Résultats | 4 nov. 2024 |
---|---|
Date du Prochain Dividende | 27 sept. 2024 |
Date du Prochain Détachement de Dividende | 12 sept. 2024 |
Atrion Corp Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
Atrion Corp prévision
À Propos Atrion Corp
Atrion Corporation (Atrion) is engaged in developing and manufacturing products primarily for medical applications. The Company markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. Its medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. Its fluid delivery products include valves designed to fill, hold and release controlled amounts of fluids or gasses in fields, such as anesthesia and oncology. Its cardiovascular product, Myocardial Protection System (MPS3), is a technology used in the open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufacture a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.